众兴菌业(002772) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was CNY 488,191,571.56, representing a 23.35% increase compared to CNY 395,772,820.20 in the same period last year[4] - Net profit attributable to shareholders decreased by 67.39% to CNY 14,162,895.37 from CNY 43,424,962.07 year-on-year[4] - The net profit after deducting non-recurring gains and losses increased by 89.67% to CNY 57,248,025.10 compared to CNY 30,182,828.36 in the previous year[4] - In Q1 2022, the company achieved operating revenue of RMB 488 million, a year-on-year increase of 23.35%[16] - The net profit attributable to shareholders, excluding non-recurring gains and losses, was RMB 57.25 million, up 89.67% year-on-year, primarily due to increased production and sales from new projects[16] - The net profit attributable to shareholders for Q1 2022 was RMB 14.16 million, a decrease of 67.39% year-on-year, mainly due to significant losses from investment products[17] - Total operating revenue for Q1 2022 was CNY 488.19 million, an increase of 23.3% compared to CNY 395.77 million in Q1 2021[23] - Net profit for Q1 2022 was CNY 14.18 million, a decrease of 67.4% from CNY 43.43 million in Q1 2021[24] Cash Flow and Assets - The net cash flow from operating activities increased by 32.61% to CNY 128,350,085.16 from CNY 96,790,084.05 in the same period last year[4] - The company's cash and cash equivalents increased to RMB 1.70 billion from RMB 1.60 billion at the beginning of the year[19] - The net cash flow from operating activities for Q1 2022 was CNY 128.35 million, an increase of 32.6% from CNY 96.79 million in Q1 2021[28] - The cash inflow from operating activities totaled CNY 484.04 million in Q1 2022, compared to CNY 414.96 million in Q1 2021[28] - The net cash flow from investment activities was -192,884,044.82 CNY, compared to a positive cash flow of 67,023,452.15 CNY in the previous year[29] - Cash inflow from financing activities totaled 321,000,000.00 CNY, down from 622,500,000.00 CNY year-over-year[29] - The net cash flow from financing activities was 171,619,688.89 CNY, compared to 277,501,790.78 CNY in the same period last year[29] - The net increase in cash and cash equivalents was 107,085,729.23 CNY, significantly lower than the 441,315,326.98 CNY increase in the previous year[29] - The ending balance of cash and cash equivalents was 1,687,876,702.27 CNY, compared to 1,641,554,501.78 CNY at the end of the previous year[29] Assets and Liabilities - Total assets at the end of the reporting period were CNY 6,743,024,882.27, a 2.93% increase from CNY 6,551,297,202.04 at the end of the previous year[4] - The total liabilities increased to RMB 3.95 billion from RMB 3.64 billion at the beginning of the year[20] - Total liabilities as of Q1 2022 were CNY 3.47 billion, an increase from CNY 3.30 billion in the previous year[24] - Total equity attributable to shareholders of the parent company was CNY 3.27 billion, up from CNY 3.25 billion year-over-year[24] Investment and R&D - Research and development expenses for Q1 2022 were CNY 253,380, an increase of 36.19% compared to the same period last year[10] - R&D expenses increased to CNY 2.53 million in Q1 2022, compared to CNY 1.86 million in Q1 2021, reflecting a growth of 35.8%[24] - The company reported a significant decrease in investment income, which was CNY 32,460, down 90.29% year-on-year due to fewer investment returns from entrusted wealth management[10] - The company reported a decrease in investment income to CNY 324.58 thousand in Q1 2022, compared to CNY 3.34 million in Q1 2021[24] - The company experienced a 1,297.58% decrease in fair value changes, reporting a loss of CNY 47,802,200 in Q1 2022[10] - The company reported a significant decline in the value of its investment products, impacting overall profitability[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 47,482[13] - The company plans to distribute a cash dividend of RMB 1.00 per 10 shares, with no bonus shares or capital reserves to be converted into shares[15] Other Information - The company's inventory decreased slightly to RMB 1.17 billion from RMB 1.17 billion at the beginning of the year[19] - The company did not undergo an audit for the first quarter report[30]